|
Leading
Article 104
Double vision for pharmacy 104
Text PDF (55K)
While politicians were packing their bags and thinking of their summer holidays, the Government
produced not one but two visions for community pharmacy in England. However, this double vision
does not, at present, make the future much clearer; if anything, the picture remains rather blurred
News & Features 105-114
News summary 105-110
Text PDF (350K)
A new vision for pharmacy in the future 111-112
Text PDF (80K)
Last Thursday, the Government published a new strategy for pharmacy
in England: "A vision
for pharmacy in the new NHS". Clare Bellingham reports
Is this deregulation by the back door? 113-114
Text PDF (135K)
The Government's proposals in response to the Office of Fair Trading report aim to introduce some exemptions
to control of entry regulations. Is this a sensible compromise or will it lead inevitably to full deregulation?
Jonathan Buisson gathers reactions
Products PDF (85K) 115
• Products Text 115
• Announcements Text 115
• Drug tariff updates Text
• Recalls Text
Broad Spectrum 116
Clinical governance and the dispensary computer: a natural alliance 116
Text PDF (60K)
By Simon Whitaker
Letters 117-120
Text PDF (100K)
Continuing Professional
Development (CPD) 121-123
Recent articles
The new National Health Service series
(1) Understanding the NHS in England 121-123
PDF
(90K)
By Georgina Craig, MA
Since the election of the Labour Government, the National Health Service has undergone much remodelling.
This article is the first in a series about the new NHS. It reviews the new structures in England
and what they mean for pharmacy.
Later articles will look at NHS structures in Scotland and Wales
Articles 124-130
Ethical issues in the development of medicinal products 124-126
Text PDF (75K)
By Robin J. Harman, PhD, MRPharmS
This article considers some of the ethical issues facing those involved in the development of medicinal
products for human use
Implications of gene therapy for hospital pharmacists 127-130
PDF (100K)
By Julie Simpson, PhD, MRPharmS, and Nicola S. Stoner, PhD, MRPharmS
In this article, the authors highlight the potential changes hospital pharmaceutical services may require
to undergo in order to meet the demands of the increasing number of gene therapy products entering clinical
trials
Reviews PDF (60K) 131
'Drugs for the treatment of respiratory disease' 131
Text
edited by Domenico Spina, Clive P. Page, William J. Metzger, Brian J. O'Connor
'Managing the patient-centered pharmacy' 131
Text
by Harry P. Hagel and John Rovers
'Systematic reviews to support evidence-based medicine: how to review and apply findings of healthcare
research' 131
Text
by Khalid S. Khan, Regina Kunz, Jos Kleijnen, Gerd Antes
Onlooker 132
Politics and values / The open mind / Exclusion principle / Derbyshire discovery 132
Text PDF (75K)
The Society PDF (85K) 133-136
News
Pass rate of 82.4 per cent in Society's summer registration examination Text 133
Obituaries & Tributes Text 133
Official notices 2001 to present
Registration examination successes Text 134-136
Diary Text
• Branch meetings
• Society meetings
• Future events
• Conferences
• Reunions |
Front Cover Picture
This week’s front cover picture (by Christopher Icha) illustrates the Government’s
decision last week to retain control of entry into pharmacy contracts in England but with some
new exemptions.
Leading article
News
News
feature
New strategy document
A new strategy document published by the Government sets out what pharmacy in England could look
like in the future.
News
News
feature
The new NHS in England
The National Health Service in England has undergone some major structural changes in the past
few years. This week’s continuing professional development article reviews the structures
of the NHS in England and what they mean for pharmacy PDF (90K)
Ethical issues in product development
An article considers some of the ethical
issues facing those involved in the development of medicinal
products for human use
Gene therapy
The potential changes that hospital pharmaceutical services may need to undergo in order to meet
the demands of the increasing number of gene therapy products entering clinical trials are
highlighted in an article PDF (100K)
| The "Broad Spectrum" feature is
open to any writer.
Contributions of around 1,200 words, commenting on topics of current
interest, should be sent to managing editor Graeme Smith (graeme.smith@pharmj.org.uk)
for consideration. |
|
* PDF files on PJ Online require Acrobat Reader 4 or later.